Literature DB >> 24083945

Co-existence of classical and alternative activation programs in macrophages responding to Toxoplasma gondii.

Veerupaxagouda Patil1, Yanlin Zhao1, Suhagi Shah1, Barbara A Fox2, Leah M Rommereim2, David J Bzik2, George S Yap3.   

Abstract

Pro-inflammatory M1 macrophages are critical for defense against intracellular pathogens while alternatively-activated M2 macrophages mediate tissue homeostasis and repair. Whether these distinct activation programs are mutually exclusive or can co-exist within the same cell is unclear. Here, we report the co-existence of these programs in Toxoplasma gondii-elicited inflammatory macrophages. This is independent of parasite expression of the virulence factor ROP16 and host cell expression of signal transducer and activator of transcription 6 (STAT6). Furthermore, this observation was recapitulated by IFN-γ and IL-4 treated bone marrow-derived macrophages in vitro. These results highlight the multi-functionality of macrophages as they respond to diverse microbial and endogenous stimuli.
Copyright © 2013 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alternative activation; Classical activation; Macrophage; Toxoplasma gondii; Virulence factor

Mesh:

Substances:

Year:  2013        PMID: 24083945      PMCID: PMC4042845          DOI: 10.1016/j.ijpara.2013.08.003

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  14 in total

1.  Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue.

Authors:  J P J Saeij; S Coller; J P Boyle; M E Jerome; M W White; J C Boothroyd
Journal:  Nature       Date:  2006-12-20       Impact factor: 49.962

2.  Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation.

Authors:  Kirk D C Jensen; Yiding Wang; Elia D Tait Wojno; Anjali J Shastri; Kenneth Hu; Lara Cornel; Erwan Boedec; Yi-Ching Ong; Yueh-hsiu Chien; Christopher A Hunter; John C Boothroyd; Jeroen P J Saeij
Journal:  Cell Host Microbe       Date:  2011-06-16       Impact factor: 21.023

3.  De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii.

Authors:  Barbara A Fox; David J Bzik
Journal:  Nature       Date:  2002-02-21       Impact factor: 49.962

4.  Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens.

Authors:  Karim C El Kasmi; Joseph E Qualls; John T Pesce; Amber M Smith; Robert W Thompson; Marcela Henao-Tamayo; Randall J Basaraba; Till König; Ulrike Schleicher; Mi-Sun Koo; Gilla Kaplan; Katherine A Fitzgerald; Elaine I Tuomanen; Ian M Orme; Thirumala-Devi Kanneganti; Christian Bogdan; Thomas A Wynn; Peter J Murray
Journal:  Nat Immunol       Date:  2008-11-02       Impact factor: 25.606

5.  Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation.

Authors:  Stephen J Jenkins; Dominik Ruckerl; Peter C Cook; Lucy H Jones; Fred D Finkelman; Nico van Rooijen; Andrew S MacDonald; Judith E Allen
Journal:  Science       Date:  2011-05-12       Impact factor: 47.728

6.  Transcriptomic analyses of murine resolution-phase macrophages.

Authors:  Melanie J Stables; Sonia Shah; Evelyn B Camon; Ruth C Lovering; Justine Newson; Jonas Bystrom; Stuart Farrow; Derek W Gilroy
Journal:  Blood       Date:  2011-10-19       Impact factor: 22.113

7.  Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control.

Authors:  Barbara A Butcher; Barbara A Fox; Leah M Rommereim; Sung Guk Kim; Kirk J Maurer; Felix Yarovinsky; De'Broski R Herbert; David J Bzik; Eric Y Denkers
Journal:  PLoS Pathog       Date:  2011-09-08       Impact factor: 6.823

8.  Chitinase dependent control of protozoan cyst burden in the brain.

Authors:  J Philip Nance; Kevin M Vannella; Danielle Worth; Clément David; David Carter; Shahani Noor; Cedric Hubeau; Lori Fitz; Thomas E Lane; Thomas A Wynn; Emma H Wilson
Journal:  PLoS Pathog       Date:  2012-11-29       Impact factor: 6.823

9.  Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis.

Authors:  Ludovic Arnold; Adeline Henry; Françoise Poron; Yasmine Baba-Amer; Nico van Rooijen; Anne Plonquet; Romain K Gherardi; Bénédicte Chazaud
Journal:  J Exp Med       Date:  2007-05-07       Impact factor: 14.307

10.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions.

Authors:  Matthias Nahrendorf; Filip K Swirski; Elena Aikawa; Lars Stangenberg; Thomas Wurdinger; Jose-Luiz Figueiredo; Peter Libby; Ralph Weissleder; Mikael J Pittet
Journal:  J Exp Med       Date:  2007-11-19       Impact factor: 14.307

View more
  11 in total

1.  Regulatory T Cells Promote Myositis and Muscle Damage in Toxoplasma gondii Infection.

Authors:  Richard M Jin; Sarah J Blair; Jordan Warunek; Reid R Heffner; Ira J Blader; Elizabeth A Wohlfert
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

2.  Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations.

Authors:  Kiah L Sanders; Barbara A Fox; David J Bzik
Journal:  Cancer Immunol Res       Date:  2015-03-24       Impact factor: 11.151

3.  siRNA Screening Identifies the Host Hexokinase 2 (HK2) Gene as an Important Hypoxia-Inducible Transcription Factor 1 (HIF-1) Target Gene in Toxoplasma gondii-Infected Cells.

Authors:  Matthew T Menendez; Crystal Teygong; Kristin Wade; Celia Florimond; Ira J Blader
Journal:  MBio       Date:  2015-06-23       Impact factor: 7.867

4.  Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.

Authors:  Fanping Kong; Omar A Saldarriaga; Heidi Spratt; E Yaneth Osorio; Bruno L Travi; Bruce A Luxon; Peter C Melby
Journal:  PLoS Pathog       Date:  2017-01-31       Impact factor: 6.823

5.  Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in mice.

Authors:  Ragab M Fereig; Yasuhiro Kuroda; Mohamad Alaa Terkawi; Motamed Elsayed Mahmoud; Yoshifumi Nishikawa
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

6.  Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity.

Authors:  Erica Bazzan; Graziella Turato; Mariaenrica Tinè; Claudia M Radu; Elisabetta Balestro; Chiara Rigobello; Davide Biondini; Marco Schiavon; Francesca Lunardi; Simonetta Baraldo; Federico Rea; Paolo Simioni; Fiorella Calabrese; Marina Saetta; Manuel G Cosio
Journal:  Respir Res       Date:  2017-02-23

7.  Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity.

Authors:  Barbara A Fox; Kiah L Sanders; Leah M Rommereim; Rebekah B Guevara; David J Bzik
Journal:  PLoS Genet       Date:  2016-07-22       Impact factor: 5.917

8.  STAT2 Signaling Regulates Macrophage Phenotype During Influenza and Bacterial Super-Infection.

Authors:  Radha Gopal; Benjamin Lee; Kevin J McHugh; Helen E Rich; Krishnaveni Ramanan; Sivanarayana Mandalapu; Michelle E Clay; Philip J Seger; Richard I Enelow; Michelle L Manni; Keven M Robinson; Javier Rangel-Moreno; John F Alcorn
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

Review 9.  Influence of the Host and Parasite Strain on the Immune Response During Toxoplasma Infection.

Authors:  Debanjan Mukhopadhyay; David Arranz-Solís; Jeroen P J Saeij
Journal:  Front Cell Infect Microbiol       Date:  2020-10-15       Impact factor: 5.293

10.  The Toxoplasma Polymorphic Effector GRA15 Mediates Seizure Induction by Modulating Interleukin-1 Signaling in the Brain.

Authors:  Taylor G Glausen; Gabriela L Carrillo; Richard M Jin; Jon P Boyle; Jeroen P J Saeij; Elizabeth A Wohlfert; Michael A Fox; Ira J Blader
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.